HomeProductsBioactive CompoundsMetabolic EnzymesMitochondrial MetabolismEthylmalonic acid
Chemical structure of CAS 601-75-2

Ethylmalonic acid

In Stock•Starting at $8 for 1 g•Purity ≥ 97%
CAS No.601-75-2
MDL No.MFCD00002668
MFC5H8O4
MW132.11
InChI KeyUKFXDFUAPNAMPJ-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 g97%$8In Stock
5 g97%$9In Stock
10 g97%$14In Stock
25 g97%$28In Stock
50 g97%$51In Stock
100 g97%$99In Stock
250 g97%$240In Stock
500 g97%$475In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Ethylmalonic acid is a dicarboxylic acid formed by substituting one methylene hydrogen of malonic acid with an ethyl group. It functions as a human metabolite and is a dicarboxylic fatty acid related to malonic acid. It is the conjugate acid of ethylmalonate and ethylmalonate(2-).

CAS No.601-75-2
Product NameEthylmalonic acid
IrritantIrritant
Signal Word:Warning
HCode:H315-H319-H335
PCode:P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro.

Neurochemical research • Vol. 28, Issue 5 • 2003
PMID: 12716029DOI: 10.1023/a:1022874103630

Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase gene.

Journal of inherited metabolic disease • Vol. 26, Issue 1 • 2003
PMID: 12872838DOI: 10.1023/a:1024019311933

Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes.

Journal of inherited metabolic disease • Vol. 26, Issue 1 • 2003
PMID: 12872841DOI: 10.1023/a:1024027630589

A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency.

Clinica chimica acta; international journal of clinical chemistry • Vol. 337, Issue 1-2 • 2003
PMID: 14568186DOI: 10.1016/j.cccn.2003.07.006

Documentation

Similar Products